Skip to main content Skip to main navigation menu Skip to site footer

Mutation of the Fas-promoter-670 gene, AA to GA in the normal cervix-epithelial-cells of high risk Indonesian mother: A case report



Abstract

Background: Normalities of the cervix-epithelial-cells (CEC) can be determined base on the cell morphology and their nucleus. If one of the cervix-epithelial-cells has gene mutations, it will form mutant clones, further growing, developing and malignant. The Fas-promoter-670 gene is allegedly associated with cervical cancer.

Case Presentation: A  30-year-old  of high-risk Indonesian mother,  has two children, on April 21th  2016 has followed Pap smear examination with thin prep method. Subjects, in this case, had normal cervix-epithelial-cells. Characteristics of the cervix-epithelial-cells include cell biometrics among others cell length, cell width, cell area, cell perimeter, nucleus area, and nucleus perimeter. Fas-promoter-670 genotype in the lymphocytes-cells is AA (normal= wild type), whereas in the cervix-epithelial-cells is GA (heterozygous mutant).

Conclusion: Based on characteristic of cell biometrics, cervix-epithelial-cells in high-risk Indonesian mother is normal. The genotype of the Fas-promoter-670 gene in the lymphocyte cells is AA, whereas in the cervix-epithelial-cells has mutation to GA.

Keywords: cervix-epithelial-cells Fas-promoter-670 gene cell biometrics cell length cell width

References

  1. HPV Information Centre. ICO/IARC Information Centre on HPV and Cancer. 2015.
  2. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S and Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 2012,131:2349-2359.
  3. Ueda M, Terai Y, Kanda K, Kanemura M, Takehara M, Yamaguchi H, Nishiyama K, Yasuda M, and Ueki M. Fas gene promoter -670 polymorphism in gynecological cancer. Int J Gynecol Cancer 2006, 16:179-82.
  4. American Cancer Society. Cervical Cancer Prevention and Early Detection. Atlanta: American Cancer Society pub, 2014. [cited 20 July 2015]. Available from: http://www.cancer.org/acs/groups/cid/ documents/webcontent/003167-pdf.pdf
  5. Park S and Lee YJ. AFM-based dual nano-mechanical phenotypes for cancer metastasis. J Biol Phys 2014, 40(4):413-419. doi: 10.1007/s10867-014-9353-0. Epub 2014 Jun 30.
  6. Zuk AK, Wen X, Dilworth S, Li D and Ghali L. Modeling and validating three-dimensional human normal cervix and cervical cancer tissues in vitro. J Biomed Res 2017, 31(3): 240-247.
  7. Yang L, Liu W, Wu H, Wang C, Ping B and Shi D. Separation of Normal and Premalignant Cervical Epithelial Cells Using Confocal Light Absorption and Scattering Spectroscopic Microscopy Ex Vivo. J Biomed and Biotechnol 2011, Article ID 214781, 5 pages doi:10.1155/2011/214781.
  8. Zheng B, Yoon SW and Lam SS. Breast cancer diagnosis based on feature extraction using a hybrid of K-means and support vector machine algorithms. Exp Syst with Appl 2014, 41(4): 1476-1482.
  9. Prinyakupt J and Pluempitiwiriyawej C. Segmentation of white blood cells and comparison of cell morphology by linear and na¨ıve Bayes classifiers. BioMed Eng Online 2015, 14(1), article 63.
  10. Paizeiev A. The Morphological Features of a Cervical Cancer Cells Membrane Under Reflected Light Microscope. GRF Davos Planet@Risk 2014, 2(4): 289-292. Special Issue on One Health (Part II/II).
  11. Su J, Xu X, He Y and Song J. Automatic detection of cervical cancer cells by a two-level cascade classification system. Analyt Cell Pathol 2016, Article ID 9535027, 11 pages. http//dx.doi.org/10.1155/2016/9535027.
  12. Cross SE, Jin YS, Rao J and Gimzewski JK. Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol 2007 Dec. 2(12):780-783. doi: 10.1038/nnano.2007.388. Epub 2007, Dec 2.
  13. Nunobiki O, Ueda M, Toji E, Yamamoto M, Akashi K, Sato N, Izuma S, Torii K, Tanaka I, Okamoto Y and Noda S. Genetic polymorphism of cancer susceptibility genes and HPV infection in cervical carci¬nogenesis. Patholog Res Int 2011: 3640-69.
  14. Farre L, Bittencourt AL, Silva-Santos G, Almeida A, Silva AC, Decanine D, Soares GM, Alcantara Jr LC, Van Dooren S, Galva˜ o-Castro C, Vandamme AM and Van Weyenbergh J. Fas–670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia. J Leukocyte Biol 2008, 83: 220-223.
  15. Parwanto MLE, Suweino S, Tjahjadi D, Senjaya H, Edy HJ, Pakpahan A. The effect of sex hormone binding globulin (SHBG) protein polymorphism on the levels of SHBG, testosterone, and insulin in healthy Indonesian men. Int J Med Sci Public Health 2016;5:799-806.
  16. Parwanto MLE and Senjaya H. Dietary intake of mother in childbearing age with BMI <18.5 kg/m2 and has heterozygous variant D327N SHBG genotype (w/v). Int J Community Med Public Health. 2017;4:409-17.
  17. Shimonishi T, Isse K, Shibata F, Aburatani, Tsuneyama K, Sabit H, Harada K, Miyazaki K, and Nakanuma Y. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance. Hepatol 2000, 32: 761-769.

How to Cite

Parwanto, M. L. E., Wratsangka, R., Guyansyah, A., & Anggraeni, K. (2019). Mutation of the Fas-promoter-670 gene, AA to GA in the normal cervix-epithelial-cells of high risk Indonesian mother: A case report. Bali Medical Journal, 8(1), 360–364. https://doi.org/10.15562/bmj.v%vi%i.1313
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
3

Total
20

Share

Search Panel

Mauritius Lambertus Edy Parwanto
Google Scholar
Pubmed
BMJ Journal

Raditya Wratsangka
Google Scholar
Pubmed
BMJ Journal

Assangga Guyansyah
Google Scholar
Pubmed
BMJ Journal

Kirana Anggraeni
Google Scholar
Pubmed
BMJ Journal